{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:04:31Z","timestamp":1789164271181,"version":"build-2803163510"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK098656"],"award-info":[{"award-number":["R01 DK098656"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG063869"],"award-info":[{"award-number":["R01 AG063869"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["P41 EB029460"],"award-info":[{"award-number":["P41 EB029460"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-026-01958-0","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T13:16:08Z","timestamp":1769778968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["In vivo imaging of glutamate uncovers the neuroprotective effects of nicotinamide riboside on excitotoxicity in an Alzheimer\u2019s mouse model"],"prefix":"10.1186","volume":"18","author":[{"given":"Anshuman","family":"Swain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayan Datt","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan B.","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halvor","family":"Juul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi Prakash Reddy","family":"Nanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Baur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"1","key":"1958_CR1","doi-asserted-by":"publisher","first-page":"e13920","DOI":"10.1111\/acel.13920","volume":"23","author":"CCS Chini","year":"2024","unstructured":"Chini CCS, Cordeiro HS, Tran NLK, Chini EN. NAD metabolism: role in senescence regulation and aging. Aging Cell. 2024;23(1):e13920.","journal-title":"Aging Cell"},{"key":"1958_CR2","doi-asserted-by":"publisher","first-page":"668491","DOI":"10.3389\/fcell.2021.668491","volume":"9","author":"X Wang","year":"2021","unstructured":"Wang X, He HJ, Xiong X, Zhou S, Wang WW, Feng L, et al. NAD(+) in alzheimer\u2019s disease: molecular mechanisms and systematic therapeutic evidence obtained in vivo. Front Cell Dev Biol. 2021;9:668491.","journal-title":"Front Cell Dev Biol"},{"key":"1958_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pneurobio.2013.06.004","volume":"108","author":"Z Chen","year":"2013","unstructured":"Chen Z, Zhong C. Decoding alzheimer\u2019s disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog Neurobiol. 2013;108:21\u201343.","journal-title":"Prog Neurobiol"},{"key":"1958_CR4","doi-asserted-by":"publisher","first-page":"111567","DOI":"10.1016\/j.mad.2021.111567","volume":"199","author":"OK Reiten","year":"2021","unstructured":"Reiten OK, Wilvang MA, Mitchell SJ, Hu Z, Fang EF. Preclinical and clinical evidence of NAD(+) precursors in health, disease, and ageing. Mech Ageing Dev. 2021;199:111567.","journal-title":"Mech Ageing Dev"},{"key":"1958_CR5","doi-asserted-by":"crossref","unstructured":"Campbell JM. Supplementation with NAD(+) and its precursors to prevent cognitive decline across disease contexts. Nutrients. 2022;14(15).","DOI":"10.3390\/nu14153231"},{"issue":"7","key":"1958_CR6","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1007\/s12031-021-01842-6","volume":"71","author":"L Hosseini","year":"2021","unstructured":"Hosseini L, Mahmoudi J, Pashazadeh F, Salehi-Pourmehr H, Sadigh-Eteghad S. Protective effects of nicotinamide adenine dinucleotide and related precursors in alzheimer\u2019s disease: A systematic review of preclinical studies. J Mol Neurosci. 2021;71(7):1425\u201335.","journal-title":"J Mol Neurosci"},{"issue":"8","key":"1958_CR7","doi-asserted-by":"publisher","first-page":"E1876","DOI":"10.1073\/pnas.1718819115","volume":"115","author":"Y Hou","year":"2018","unstructured":"Hou Y, Lautrup S, Cordonnier S, Wang Y, Croteau DL, Zavala E, et al. NAD(+) supplementation normalizes key alzheimer\u2019s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency. P Natl Acad Sci USA. 2018;115(8):E1876\u201385.","journal-title":"P Natl Acad Sci USA"},{"issue":"3","key":"1958_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.cmet.2022.02.001","volume":"34","author":"B Brakedal","year":"2022","unstructured":"Brakedal B, Dolle C, Riemer F, Ma Y, Nido GS, Skeie GO, et al. The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in parkinson\u2019s disease. Cell Metab. 2022;34(3):396\u2013407. e6.","journal-title":"Cell Metab"},{"issue":"6","key":"1958_CR9","first-page":"2284","volume":"92","author":"RPR Nanga","year":"2024","unstructured":"Nanga RPR, Wiers CE, Elliott MA, Wilson NE, Liu F, Cao Q, et al. Acute nicotinamide riboside supplementation increases human cerebral NAD(+) levels in vivo. Magn Reson Med. 2024;92(6):2284\u201393.","journal-title":"Magn Reson Med"},{"issue":"12","key":"1958_CR10","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1093\/gerona\/glad106","volume":"78","author":"KA Freeberg","year":"2023","unstructured":"Freeberg KA, Udovich CC, Martens CR, Seals DR, Craighead DH. Dietary supplementation with NAD+-Boosting compounds in humans: current knowledge and future directions. J Gerontol Biol Sci Med Sci. 2023;78(12):2435\u201348.","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"9","key":"1958_CR11","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1177\/0271678X21996176","volume":"41","author":"ND Soni","year":"2021","unstructured":"Soni ND, Ramesh A, Roy D, Patel AB. Brain energy metabolism in intracerebroventricularly administered streptozotocin mouse model of alzheimer\u2019s disease: A (1)H-[(13)C]-NMR study. J Cereb Blood Flow Metab. 2021;41(9):2344\u201355.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1958_CR12","doi-asserted-by":"crossref","unstructured":"Soni ND, Swain A, Juul H, Cao Q, Haris M, WolkDA, et al. Detection of sex-specific glutamate changes in subregions ofhippocampus in an early-stage Alzheimer's disease mouse model using GluCESTMRI. Alzheimers Dement. 2024;20(10):7124\u201337.","DOI":"10.1002\/alz.14190"},{"key":"1958_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jmr.2012.11.024","volume":"229","author":"E Vinogradov","year":"2013","unstructured":"Vinogradov E, Sherry AD, Lenkinski RE. CEST: from basic principles to applications, challenges and opportunities. J Magn Reson. 2013;229:155\u201372.","journal-title":"J Magn Reson"},{"issue":"2","key":"1958_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1002\/cmmi.369","volume":"5","author":"E Terreno","year":"2010","unstructured":"Terreno E, Castelli DD, Aime S. Encoding the frequency dependence in MRI contrast media: the emerging class of CEST agents. Contrast Media Mol Imaging. 2010;5(2):78\u201398.","journal-title":"Contrast Media Mol Imaging"},{"issue":"1","key":"1958_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/jmri.25838","volume":"47","author":"KM Jones","year":"2018","unstructured":"Jones KM, Pollard AC, Pagel MD. Clinical applications of chemical exchange saturation transfer (CEST) MRI. J Magn Reson Imaging. 2018;47(1):11\u201327.","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"1958_CR16","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nm.2615","volume":"18","author":"K Cai","year":"2012","unstructured":"Cai K, Haris M, Singh A, Kogan F, Greenberg JH, Hariharan H, et al. Magnetic resonance imaging of glutamate. Nat Med. 2012;18(2):302\u20136.","journal-title":"Nat Med"},{"issue":"6","key":"1958_CR17","doi-asserted-by":"publisher","first-page":"e4780","DOI":"10.1002\/nbm.4780","volume":"36","author":"ATJ Cember","year":"2023","unstructured":"Cember ATJ, Nanga RPR, Reddy R. Glutamate-weighted CEST (gluCEST) imaging for mapping neurometabolism: an update on the state of the Art and emerging findings from in vivo applications. Nmr Biomed. 2023;36(6):e4780.","journal-title":"Nmr Biomed"},{"issue":"1","key":"1958_CR18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41597-021-01054-y","volume":"8","author":"S Forner","year":"2021","unstructured":"Forner S, Kawauchi S, Balderrama-Gutierrez G, Kramar EA, Matheos DP, Phan J, et al. Systematic phenotyping and characterization of the 5xFAD mouse model of alzheimer\u2019s disease. Sci Data. 2021;8(1):270.","journal-title":"Sci Data"},{"issue":"1","key":"1958_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1503\/jpn.110190","volume":"38","author":"TJ Revett","year":"2013","unstructured":"Revett TJ, Baker GB, Jhamandas J, Kar S. Glutamate system, amyloid Ss peptides and Tau protein: functional interrelationships and relevance to alzheimer disease pathology. J Psychiatr Neurosci. 2013;38(1):6\u201323.","journal-title":"J Psychiatr Neurosci"},{"issue":"5","key":"1958_CR20","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.neuint.2004.03.007","volume":"45","author":"MR Hynd","year":"2004","unstructured":"Hynd MR, Scott HL, Dodd PR. Glutamate-mediated excitotoxicity and neurodegeneration in alzheimer\u2019s disease. Neurochem Int. 2004;45(5):583\u201395.","journal-title":"Neurochem Int"},{"issue":"3","key":"1958_CR21","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12031-025-02379-8","volume":"75","author":"M Sil","year":"2025","unstructured":"Sil M, Mukherjee N, Chatterjee I, Ghosh A, Goswami A. Glial cells in alzheimer\u2019s disease: pathogenic mechanisms and therapeutic frontiers. J Mol Neurosci. 2025;75(3):87.","journal-title":"J Mol Neurosci"},{"issue":"6","key":"1958_CR22","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1093\/brain\/awae126","volume":"147","author":"AJ Barbour","year":"2024","unstructured":"Barbour AJ, Gourmaud S, Lancaster E, Li XF, Stewart DA, Hoag KF, et al. Seizures exacerbate excitatory: inhibitory imbalance in alzheimer\u2019s disease and 5XFAD mice. Brain. 2024;147(6):2169\u201384.","journal-title":"Brain"},{"issue":"6","key":"1958_CR23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/j.1469-7580.2007.00733.x","volume":"210","author":"C Matute","year":"2007","unstructured":"Matute C, Alberdi E, Domercq M, Sanchez-Gomez MV, Perez-Samartin A, Rodriguez-Antiguedad A, et al. Excitotoxic damage to white matter. J Anat. 2007;210(6):693\u2013702.","journal-title":"J Anat"},{"issue":"2","key":"1958_CR24","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.cmet.2016.07.005","volume":"24","author":"DW Frederick","year":"2016","unstructured":"Frederick DW, Loro E, Liu L, Davila A Jr., Chellappa K, Silverman IM, et al. Loss of NAD homeostasis leads to progressive and reversible degeneration of skeletal muscle. Cell Metab. 2016;24(2):269\u201382.","journal-title":"Cell Metab"},{"issue":"2","key":"1958_CR25","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/hep.28912","volume":"65","author":"S Mukherjee","year":"2017","unstructured":"Mukherjee S, Chellappa K, Moffitt A, Ndungu J, Dellinger RW, Davis JG, et al. Nicotinamide adenine dinucleotide biosynthesis promotes liver regeneration. Hepatology. 2017;65(2):616\u201330.","journal-title":"Hepatology"},{"issue":"6","key":"1958_CR26","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/mrm.21873","volume":"61","author":"M Kim","year":"2009","unstructured":"Kim M, Gillen J, Landman BA, Zhou J, van Zijl PC. Water saturation shift referencing (WASSR) for chemical exchange saturation transfer (CEST) experiments. Magn Reson Med. 2009;61(6):1441\u201350.","journal-title":"Magn Reson Med"},{"issue":"3","key":"1958_CR27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s12021-020-09453-z","volume":"18","author":"Y Liu","year":"2020","unstructured":"Liu Y, Unsal HS, Tao Y, Zhang N. Automatic brain extraction for rodent MRI images. Neuroinformatics. 2020;18(3):395\u2013406.","journal-title":"Neuroinformatics"},{"issue":"6","key":"1958_CR28","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1109\/TMI.2010.2046908","volume":"29","author":"NJ Tustison","year":"2010","unstructured":"Tustison NJ, Avants BB, Cook PA, Zheng Y, Egan A, Yushkevich PA, et al. N4ITK: improved N3 bias correction. IEEE Trans Med Imaging. 2010;29(6):1310\u201320.","journal-title":"IEEE Trans Med Imaging"},{"issue":"6","key":"1958_CR29","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/(SICI)1522-2594(199912)42:6<1072::AID-MRM11>3.0.CO;2-M","volume":"42","author":"LG Nyul","year":"1999","unstructured":"Nyul LG, Udupa JK. On standardizing the MR image intensity scale. Magn Reson Med. 1999;42(6):1072\u201381.","journal-title":"Magn Reson Med"},{"issue":"1","key":"1958_CR30","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.neuroimage.2008.03.037","volume":"42","author":"AE Dorr","year":"2008","unstructured":"Dorr AE, Lerch JP, Spring S, Kabani N, Henkelman RM. High resolution three-dimensional brain atlas using an average magnetic resonance image of 40 adult C57Bl\/6J mice. NeuroImage. 2008;42(1):60\u20139.","journal-title":"NeuroImage"},{"issue":"3","key":"1958_CR31","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1016\/j.neuroimage.2010.09.025","volume":"54","author":"BB Avants","year":"2011","unstructured":"Avants BB, Tustison NJ, Song G, Cook PA, Klein A, Gee JC. A reproducible evaluation of ants similarity metric performance in brain image registration. NeuroImage. 2011;54(3):2033\u201344.","journal-title":"NeuroImage"},{"issue":"3","key":"1958_CR32","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1016\/j.neuroimage.2009.09.062","volume":"49","author":"BB Avants","year":"2010","unstructured":"Avants BB, Yushkevich P, Pluta J, Minkoff D, Korczykowski M, Detre J, et al. The optimal template effect in hippocampus studies of diseased populations. NeuroImage. 2010;49(3):2457\u201366.","journal-title":"NeuroImage"},{"key":"1958_CR33","doi-asserted-by":"publisher","first-page":"1266859","DOI":"10.3389\/fnagi.2023.1266859","volume":"15","author":"A Swain","year":"2023","unstructured":"Swain A, Soni ND, Wilson N, Juul H, Benyard B, Haris M, et al. Early-stage mapping of macromolecular content in APP(NL-F) mouse model of alzheimer\u2019s disease using nuclear overhauser effect MRI. Front Aging Neurosci. 2023;15:1266859.","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"1958_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1109\/TIP.2012.2210725","volume":"22","author":"M Maggioni","year":"2013","unstructured":"Maggioni M, Katkovnik V, Egiazarian K, Foi A. Nonlocal transform-domain filter for volumetric data denoising and reconstruction. IEEE Trans Image Process. 2013;22(1):119\u201333.","journal-title":"IEEE Trans Image Process"},{"key":"1958_CR35","doi-asserted-by":"publisher","first-page":"110025","DOI":"10.1016\/j.jneumeth.2023.110025","volume":"402","author":"L Luijerink","year":"2024","unstructured":"Luijerink L, Rodriguez M, Machaalani R. Quantifying GFAP immunohistochemistry in the brain - Introduction of the reactivity score (R-score) and how it compares to other methodologies. J Neurosci Methods. 2024;402:110025.","journal-title":"J Neurosci Methods"},{"key":"1958_CR36","doi-asserted-by":"crossref","unstructured":"Marques SI, Carmo H, Carvalho F, Sa SI, Silva JP. A Semi-Automatic method for the quantification of astrocyte number and branching in bulk immunohistochemistry images. Int J Mol Sci. 2023;24(5).","DOI":"10.3390\/ijms24054508"},{"key":"1958_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0079-6123(07)63001-5","volume":"163","author":"DG Amaral","year":"2007","unstructured":"Amaral DG, Scharfman HE, Lavenex P. The dentate gyrus: fundamental neuroanatomical organization (dentate gyrus for dummies). Prog Brain Res. 2007;163:3\u201322.","journal-title":"Prog Brain Res"},{"issue":"2","key":"1958_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13205-022-03123-4","volume":"12","author":"YL Rao","year":"2022","unstructured":"Rao YL, Ganaraja B, Murlimanju BV, Joy T, Krishnamurthy A, Agrawal A. Hippocampus and its involvement in alzheimer\u2019s disease: a review. 3 Biotech. 2022;12(2):55.","journal-title":"3 Biotech"},{"issue":"10","key":"1958_CR39","doi-asserted-by":"publisher","first-page":"7369","DOI":"10.1002\/alz.14179","volume":"20","author":"JN Geigenmuller","year":"2024","unstructured":"Geigenmuller JN, Tari AR, Wisloff U, Walker TL. The relationship between adult hippocampal neurogenesis and cognitive impairment in alzheimer\u2019s disease. Alzheimers Dement. 2024;20(10):7369\u201383.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"1958_CR40","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1750-3639.1994.tb00838.x","volume":"4","author":"LF Eng","year":"1994","unstructured":"Eng LF, Ghirnikar RS. GFAP and astrogliosis. Brain Pathol. 1994;4(3):229\u201337.","journal-title":"Brain Pathol"},{"issue":"7","key":"1958_CR41","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1111\/epi.16918","volume":"62","author":"H Dejakaisaya","year":"2021","unstructured":"Dejakaisaya H, Kwan P, Jones NC. Astrocyte and glutamate involvement in the pathogenesis of epilepsy in alzheimer\u2019s disease. Epilepsia. 2021;62(7):1485\u201393.","journal-title":"Epilepsia"},{"key":"1958_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.neures.2017.11.012","volume":"126","author":"H Chun","year":"2018","unstructured":"Chun H, Lee CJ. Reactive astrocytes in alzheimer\u2019s disease: A double-edged sword. Neurosci Res. 2018;126:44\u201352.","journal-title":"Neurosci Res"},{"issue":"1","key":"1958_CR43","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41398-022-02024-7","volume":"12","author":"H Targa Dias Anastacio","year":"2022","unstructured":"Targa Dias Anastacio H, Matosin N, Ooi L. Neuronal hyperexcitability in alzheimer\u2019s disease: what are the drivers behind this aberrant phenotype? Transl Psychiatry. 2022;12(1):257.","journal-title":"Transl Psychiatry"},{"key":"1958_CR44","doi-asserted-by":"crossref","unstructured":"Di Benedetto G, Burgaletto C, Bellanca CM, Munafo A, Bernardini R, Cantarella G. Role of Microglia and Astrocytes in Alzheimer\u2019s Disease: From Neuroinflammation to Ca(2+) Homeostasis Dysregulation. Cells. 2022;11(17).","DOI":"10.3390\/cells11172728"},{"issue":"2","key":"1958_CR45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0896-6273(03)00850-X","volume":"41","author":"RB DeMattos","year":"2004","unstructured":"DeMattos RB, Cirrito JR, Parsadanian M, May PC, O\u2019Dell MA, Taylor JW, et al. ApoE and clusterin cooperatively suppress Abeta levels and deposition: evidence that ApoE regulates extracellular Abeta metabolism in vivo. Neuron. 2004;41(2):193\u2013202.","journal-title":"Neuron"},{"key":"1958_CR46","doi-asserted-by":"crossref","unstructured":"Paiva BS, Neves D, Tome D, Costa FJ, Bruno IC, Trigo D et al. Neuroprotection by mitochondrial NAD against Glutamate-Induced excitotoxicity. Cells. 2025;14(8).","DOI":"10.3390\/cells14080582"},{"key":"1958_CR47","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1196\/annals.1427.028","volume":"1147","author":"D Liu","year":"2008","unstructured":"Liu D, Pitta M, Mattson MP. Preventing NAD(+) depletion protects neurons against excitotoxicity: bioenergetic effects of mild mitochondrial uncoupling and caloric restriction. Ann N Y Acad Sci. 2008;1147:275\u201382.","journal-title":"Ann N Y Acad Sci"},{"key":"1958_CR48","doi-asserted-by":"publisher","first-page":"102745","DOI":"10.1016\/j.redox.2023.102745","volume":"63","author":"HR Li","year":"2023","unstructured":"Li HR, Liu Q, Zhu CL, Sun XY, Sun CY, Yu CM, et al. beta-Nicotinamide mononucleotide activates NAD+\/SIRT1 pathway and attenuates inflammatory and oxidative responses in the hippocampus regions of septic mice. Redox Biol. 2023;63:102745.","journal-title":"Redox Biol"},{"issue":"1","key":"1958_CR49","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s12017-009-8058-1","volume":"11","author":"D Liu","year":"2009","unstructured":"Liu D, Gharavi R, Pitta M, Gleichmann M, Mattson MP. Nicotinamide prevents NAD\u2009+\u2009depletion and protects neurons against excitotoxicity and cerebral ischemia: NAD\u2009+\u2009consumption by SIRT1 May endanger energetically compromised neurons. Neuromolecular Med. 2009;11(1):28\u201342.","journal-title":"Neuromolecular Med"},{"key":"1958_CR50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1073\/pnas.2011226118","volume":"118","author":"Y Hou","year":"2021","unstructured":"Hou Y, Wei Y, Lautrup S, Yang B, Wang Y, Cordonnier S, et al. NAD(+) supplementation reduces neuroinflammation and cell senescence in a Transgenic mouse model of alzheimer\u2019s disease via cGAS-STING. P Natl Acad Sci USA. 2021;118:37.","journal-title":"P Natl Acad Sci USA"},{"key":"1958_CR51","doi-asserted-by":"publisher","first-page":"106645","DOI":"10.1016\/j.nbd.2024.106645","volume":"200","author":"A Marmolejo-Garza","year":"2024","unstructured":"Marmolejo-Garza A, Chatre L, Croteau DL, Herron-Bedoya A, Luu MDA, Bernay B, et al. Nicotinamide riboside modulates the reactive species interactome, bioenergetic status and proteomic landscape in a brain-region-specific manner. Neurobiol Dis. 2024;200:106645.","journal-title":"Neurobiol Dis"},{"key":"1958_CR52","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/B978-0-12-385157-4.01161-1","volume-title":"Encyclopedia of the neurological sciences","author":"BL Walter","year":"2014","unstructured":"Walter BL, Shaikh AG. Midbrain. In: Aminoff MJ, Daroff RB, editors. Encyclopedia of the neurological sciences. Oxford: Academic; 2014. pp. 28\u201333."},{"issue":"4","key":"1958_CR53","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.3233\/JAD-230441","volume":"95","author":"K Sakurai","year":"2023","unstructured":"Sakurai K, Kaneda D, Morimoto S, Uchida Y, Inui S, Kimura Y, et al. Asymmetric cerebral peduncle atrophy: A simple diagnostic clue for distinguishing frontotemporal Lobar degeneration from alzheimer\u2019s disease. J Alzheimers Dis. 2023;95(4):1657\u201365.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1958_CR54","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11011-018-0346-8","volume":"34","author":"X Xie","year":"2019","unstructured":"Xie X, Gao Y, Zeng M, Wang Y, Wei TF, Lu YB, et al. Nicotinamide ribose ameliorates cognitive impairment of aged and alzheimer\u2019s disease model mice. Metab Brain Dis. 2019;34(1):353\u201366.","journal-title":"Metab Brain Dis"},{"issue":"10","key":"1958_CR55","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.molmed.2017.08.001","volume":"23","author":"EF Fang","year":"2017","unstructured":"Fang EF, Lautrup S, Hou Y, Demarest TG, Croteau DL, Mattson MP, et al. NAD(+) in aging: molecular mechanisms and translational implications. Trends Mol Med. 2017;23(10):899\u2013916.","journal-title":"Trends Mol Med"},{"issue":"11","key":"1958_CR56","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nrm.2016.93","volume":"17","author":"MS Bonkowski","year":"2016","unstructured":"Bonkowski MS, Sinclair DA. Slowing ageing by design: the rise of NAD(+) and sirtuin-activating compounds. Nat Rev Mol Cell Biol. 2016;17(11):679\u201390.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1958_CR57","doi-asserted-by":"publisher","first-page":"149590","DOI":"10.1016\/j.bbrc.2024.149590","volume":"702","author":"T Iqbal","year":"2024","unstructured":"Iqbal T, Nakagawa T. The therapeutic perspective of NAD(+) precursors in age-related diseases. Biochem Biophys Res Commun. 2024;702:149590.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"1958_CR58","doi-asserted-by":"publisher","first-page":"5440","DOI":"10.1096\/fj.201700221RR","volume":"31","author":"P Vaur","year":"2017","unstructured":"Vaur P, Brugg B, Mericskay M, Li Z, Schmidt MS, Vivien D, et al. Nicotinamide riboside, a form of vitamin B(3), protects against excitotoxicity-induced axonal degeneration. Faseb J. 2017;31(12):5440\u201352.","journal-title":"Faseb J"},{"issue":"41","key":"1958_CR59","doi-asserted-by":"publisher","first-page":"8644","DOI":"10.1523\/JNEUROSCI.2264-20.2021","volume":"41","author":"MR Langley","year":"2021","unstructured":"Langley MR, Choi CI, Peclat TR, Guo Y, Simon WL, Yoon H, et al. Critical role of astrocyte NAD(+) glycohydrolase in Myelin injury and regeneration. J Neurosci. 2021;41(41):8644\u201367.","journal-title":"J Neurosci"},{"key":"1958_CR60","doi-asserted-by":"publisher","first-page":"1201317","DOI":"10.3389\/fncel.2023.1201317","volume":"17","author":"SI Kaplanis","year":"2023","unstructured":"Kaplanis SI, Kaffe D, Ktena N, Lygeraki A, Kolliniati O, Savvaki M, et al. Nicotinamide enhances Myelin production after demyelination through reduction of astrogliosis and microgliosis. Front Cell Neurosci. 2023;17:1201317.","journal-title":"Front Cell Neurosci"},{"issue":"2","key":"1958_CR61","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/jnc.15367","volume":"158","author":"J Roboon","year":"2021","unstructured":"Roboon J, Hattori T, Ishii H, Takarada-Iemata M, Nguyen DT, Heer CD, et al. Inhibition of CD38 and supplementation of nicotinamide riboside ameliorate lipopolysaccharide-induced microglial and astrocytic neuroinflammation by increasing NAD(). J Neurochem. 2021;158(2):311\u201327.","journal-title":"J Neurochem"},{"issue":"2","key":"1958_CR62","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3233\/JAD-210523","volume":"85","author":"A Sil","year":"2022","unstructured":"Sil A, Erfani A, Lamb N, Copland R, Riedel G, Platt B. Sex differences in behavior and molecular pathology in the 5XFAD model. J Alzheimers Dis. 2022;85(2):755\u201378.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1958_CR63","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/JAD-170672","volume":"62","author":"J Folch","year":"2018","unstructured":"Folch J, Busquets O, Ettcheto M, Sanchez-Lopez E, Castro-Torres RD, Verdaguer E, et al. Memantine for the treatment of dementia: A review on its current and future applications. J Alzheimers Dis. 2018;62(3):1223\u201340.","journal-title":"J Alzheimers Dis"},{"issue":"2\u20133","key":"1958_CR64","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0014-2999(02)01847-2","volume":"447","author":"C Matute","year":"2002","unstructured":"Matute C, Alberdi E, Ibarretxe G, Sanchez-Gomez MV. Excitotoxicity in glial cells. Eur J Pharmacol. 2002;447(2\u20133):239\u201346.","journal-title":"Eur J Pharmacol"},{"key":"1958_CR65","doi-asserted-by":"publisher","first-page":"713726","DOI":"10.3389\/fnagi.2021.713726","volume":"13","author":"AL Oblak","year":"2021","unstructured":"Oblak AL, Lin PB, Kotredes KP, Pandey RS, Garceau D, Williams HM, et al. Comprehensive evaluation of the 5XFAD mouse model for preclinical testing applications: A MODEL-AD study. Front Aging Neurosci. 2021;13:713726.","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"1958_CR66","doi-asserted-by":"publisher","first-page":"e0212002","DOI":"10.1371\/journal.pone.0212002","volume":"14","author":"M Yanez Lopez","year":"2019","unstructured":"Yanez Lopez M, Pardon MC, Baiker K, Prior M, Yuchun D, Agostini A, et al. Myoinositol CEST signal in animals with increased Iba-1 levels in response to an inflammatory challenge-Preliminary findings. PLoS ONE. 2019;14(2):e0212002.","journal-title":"PLoS ONE"},{"issue":"1","key":"1958_CR67","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jneumeth.2012.09.025","volume":"212","author":"M Haris","year":"2013","unstructured":"Haris M, Singh A, Cai K, Nath K, Crescenzi R, Kogan F, et al. MICEST: a potential tool for non-invasive detection of molecular changes in alzheimer\u2019s disease. J Neurosci Methods. 2013;212(1):87\u201393.","journal-title":"J Neurosci Methods"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-026-01958-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-01958-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-01958-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:02:52Z","timestamp":1770897772000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-026-01958-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1958"],"URL":"https:\/\/doi.org\/10.1186\/s13195-026-01958-0","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were carried out using a protocol approved by the Institutional Animal Use & Care committee at the University of Pennsylvania.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Joseph Baur reports receiving research funding and materials from Pfizer, Elysium Health and Metro International Biotech and consulting fees from Pfizer, Elysium Health, Altimmune, and Cytokinetics; he holds a patent for using NAD+ precursors in liver injury.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}